Dong-soo Suh
Yangsan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Clinical Outcomes of Poly(ADP-Ribose) Polymerase Inhibitors as Maintenance Therapy in Patients with Ovarian Cancer in the Southeastern Region of Korea.
Journal: Current oncology (Toronto, Ont.)
Published: September 22, 2024
Identification of CD109 in the extracellular vesicles derived from ovarian cancer stem-like cells.
Journal: BMB reports
Published: January 15, 2024
BBT-877, a Novel Autotaxin Inhibitor, Abrogates Drug Resistance in Epithelial Ovarian Cancer Stem Cells.
Journal: Anticancer research
Published: September 22, 2023
CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis.
Journal: International journal of molecular sciences
Published: March 28, 2023
TRRAP Enhances Cancer Stem Cell Characteristics by Regulating NANOG Protein Stability in Colon Cancer Cells.
Journal: International journal of molecular sciences
Published: February 07, 2023
TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis.
Journal: Molecules and cells
Published: February 03, 2021
CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
Journal: BMB reports
Published: May 13, 2020
TRRAP stimulates the tumorigenic potential of ovarian cancer stem cells.
Journal: BMB reports
Published: February 22, 2018
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer.
Journal: Oncotarget
Published: February 11, 2016
Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Journal: Experimental & molecular medicine
Published: December 24, 2015
Last Updated: 09/26/2026